April 20, 2018

Baxter (BAX)

Upgrades - Downgrades image

Baxter Intl (BAX) has not been on an amazing tear this year and is vastly underperforming the S&P 500 wit a mere 9.5% gain YTD vs the broad market’s 20% but Goldman Sachs thinks that is all about to change. Today Goldman Reinstated BAX with a Conviction Buy rating and an $86 price target which using today’s closing price of $71.64 means that Goldman sees a roughly 20% price increase coming in BAX.  Being that it was added to the Conviction Buy rating, as I have noted before, this makes me believe Goldman thinks the gains should be coming sooner…